PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1789446
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1789446
Negative Pressure Wound Therapy (NPWT) Devices Market is estimated to be valued at USD 2,763.8 Mn in 2025 and is expected to reach USD 4,294.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2024 | Market Size in 2025: | USD 2,763.8 Mn |
Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
Forecast Period 2025 to 2032 CAGR: | 6.50% | 2032 Value Projection: | USD 4,294.9 Mn |
Negative-pressure wound therapy (NPWT), also known as vacuum-assisted wound closure, refers to wound dressing systems that continuously or intermittently apply sub-atmospheric pressure to the system, creating positive pressure on the surface of a wound. Negative-pressure therapy technology has gained popularity as a management technique for various acute and chronic wounds or surgical wounds. Benefits of negative-pressure wound therapy include faster wound granulation and re-epithelialization, reduction of bacterial load, and increased tissue oxygenation.
Rise in adoption of advanced NPWT systems, which include open-pore foam sponge, adhesive dressing, and vacuum pump, is driving the global market. Additionally, negative-pressure wound therapy technology provides advantages such as better healing of transplanted skin and shorter hospital stay for patients receiving split-thickness skin grafts. Recent improvements in negative-pressure wound therapy (NPWT) devices, such as increased accuracy and efficiency in smart pressure portable NPWT devices, has led to an increase in demand for these devices. In developed countries, demand for NPWT devices is increasing in homecare settings due to safety features, easy handling, and high awareness about the devices.
Increasing awareness regarding chronic wounds and its treatments is expected to drive the market growth. Moreover, increase in the prevalence of global burden of diabetes and increase in the prevalence of chronic wounds and ulcer is expected to drive the growth of the negative-pressure wound therapy (NPWT) devices market for the forecast period. For instance, according to a study titled 'An estimate of the economic burden of venous leg ulcers associated with deep venous disease' published by National Center for Biotechnology Information, in August 2021 reported that venous leg ulcers (VLU) account for 70% of all chronic leg ulcers and are associated with a recurrence rate of 60-70% at 10 years, globally. The deep venous ulcers are responsible for 90% of the venous return to the right atrium from the lower extremities. Such a recurrence of the condition creates the need for NPWT devices and is thus expected to drive the growth of the market.
Key features of the study